Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Aging (Albany NY) ; 16(3): 2181-2193, 2024 01 25.
Article in English | MEDLINE | ID: mdl-38277217

ABSTRACT

AIM: (-)-Epicatechin (EPI) has physiological activities such as antioxidant, anti-inflammatory and immune enhancement. In this study, we elucidated the protective effects of EPI in myocardial ischemia/reperfusion injury (MI/RI) and its mechanisms. METHODS: An in vivo I/R model was constructed by performing left anterior descending coronary artery surgery on rats, and an in vitro I/R model was constructed by subjecting hypoxia/reperfusion treatment on H9C2 cells. The damage of cardiac tissues was detected by 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin (H&E) staining, and expressions of ferroptosis-related proteins were examined by Western blot. Changes in the number of autophagosomes, the levels of oxidative stress and Fe2+ were also examined. RESULTS: EPI reduced abnormal electrocardiogram waveform and infarct size caused by MI/RI in rats. The increasing trend of levels of reactive oxygen species (ROS) and Fe2+ was reversed by EPI, suggesting that EPI can reduce ferroptosis in vivo. Moreover, the levels of lipid ROS and LC3 in H9C2 cells were decreased with EPI treatment, and autophagy and ferroptosis were also alleviated in a dose-dependent manner in vitro. Co-cultivation of USP14 inhibitor IU1 and EPI further revealed that EPI regulates ferroptosis through the USP14-autophagy pathway. CONCLUSIONS: EPI can reduce the level of oxidative stress by promoting USP14 to reduce autophagy, thus inhibiting autophagy dependent ferroptosis and reducing oxidative stress, and has a protective effect on myocardial infarction/myocardial infarction.


Subject(s)
Catechin , Ferroptosis , Myocardial Infarction , Myocardial Reperfusion Injury , Rats , Animals , Catechin/pharmacology , Catechin/therapeutic use , Reactive Oxygen Species/metabolism , Rats, Sprague-Dawley , Myocardial Reperfusion Injury/prevention & control , Myocardial Reperfusion Injury/metabolism , Autophagy , Myocardial Infarction/metabolism
2.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-280983

ABSTRACT

In the trials of multi-glycoside of Tripterygium wilfordii (GTW) in the field of pharmacodynamics, some clinical characteristics and symptoms, such as proteinuria, hematuria,joint pain, and skin damage, could be improved in the patients with various diseases including proliferative glomerulonephritis, lupus nephritis, rheumatoid arthritis, psoriasis and other immune-related diseases. In this review, it has been also reported to discuss the effects of GTW and Triptolide (T4), which is a bioactive component in GTW on anti-inflammatory, immunosuppression, and protection of epithelial cell in kidney. On the other hand, it is possible to have some beneficial effects on organ transplant rejection, tumor growth and anti-fertility.


Subject(s)
Animals , Humans , Biomedical Research , Drug Therapy , Drugs, Chinese Herbal , Pharmacokinetics , Therapeutic Uses , Pharmacology , Tripterygium , Chemistry
3.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-263098

ABSTRACT

The pathomechanisms of the progression of chronic kidney disease (CKD) include glomerulosclerosis, renal interstitial fibrosis and renal arteriosclerosis. Chinese herbal medicine can delay the progression of CKD by ameliorating the harmful factors of these pathological changes, such as podocyte and slit diaphragm injury, nephrotoxicity of proteinuria, hyperactivity of renin-angiotensin-aldosterone system, cytokines over-expression, tubular epithelial myofibroblast transdifferentiation, hyperlipidemia and hypertension.


Subject(s)
Humans , Chronic Disease , Drugs, Chinese Herbal , Pharmacology , Therapeutic Uses , Kidney Diseases , Drug Therapy , Metabolism , Renin-Angiotensin System , Transforming Growth Factor beta , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...